BioCentury | Jan 8, 2021
Finance
Venrock stays modest with $450M ninth fund as it continues to seek disruptive, early-stage tech
...will be allocated to healthcare, and the remainder to technology. Recent therapeutics investments include targeted radiotherapy play RayzeBio Inc....